Enabling extended use of its life science intelligence
solutions to help companies accelerate innovation
LONDON and PHILADELPHIA, Dec. 5,
2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:
CCC; CCC.WS), a global leader in providing trusted insights and
analytics to accelerate the pace of innovation, today announced
that it has signed alliance agreements with three new technology
partners. The partnerships will see Clarivate combine content from
its Cortellis™ suite of life science intelligence solutions with
partners' tools and technologies to help drug and medical device
developers be better positioned for clinical and financial
success.
The new partners include:
Blueprint Systems
Blueprint Systems is a
Gartner-recognized agile planning and compliance management
software provider that accelerates and de-risks the digital
transformation of large organizations. Its exclusive collaboration
with Clarivate tackles one of the biggest challenges in life
sciences—efficiently and successfully managing the complex
regulatory compliance and GxP process.
Copyright Clearance Center
Copyright Clearance Center
(CCC) provides solutions that combine licensing, content, software
and professional services to advance the way companies integrate,
access and share information. Through its partnership with
Clarivate, CCC has expanded the capabilities of its RightFind®
Navigate discovery solution, which provides contextualized
information retrieval of internal and external data to meet the
specific needs of each user.
Remarque Systems
A leader in innovative clinical
research methods, Remarque Systems optimizes clinical trials
through data using its cloud-based platform. Clarivate and Remarque
are exploring ways to leverage Cortellis Clinical Trials
intelligence in Remarque's AI-driven quality oversight and trial
optimization software.
"Partnering with these innovative technology companies
demonstrates how Clarivate continues to deliver improved value to
drug and medical device developers by unlocking hidden insights in
data," said Gavin Coney, Global Head
of Science Group Alliances for Clarivate Analytics. "Our vision is
to improve how the world advances innovation. One way we do this is
by partnering with forward-looking companies that can add
considerable value to our solutions. Specifically, these three
partnerships will help us combine expertise and tools to create
solutions that address some of the industry's most urgent
challenges, such as new scientific discoveries, regulatory
compliance, efficient clinical development and more proactive risk
management. These partners are the latest to join our life science
alliance program, announced earlier this year."
As a result of the partnerships, life sciences companies can
expect to see better return on their investment in data and content
by optimizing their R&D budgets. The combined solutions will
drive workflow efficiencies by making it easier to track
information and manage data, which means teams can free up
resources to focus on more strategic work rather than manually
compiling and maintaining complex information sets. The extended
solutions will also enable users to better access and interpret
data in new ways, helping them move from research to insights and
decision-making much faster.
The enhanced capabilities from the combination with partner
solutions will be enabled by Cortellis Cloud™, an integrated,
scalable technology platform that hosts Cortellis. Through
Cortellis Cloud, millions of datapoints from thousands of sources
are harmonized within a single unified platform, making it the
industry's richest resource for data-driven insights and advanced
analytics.
Cortellis intelligence spans the entire R&D lifecycle and
includes 2 million+ molecular interactions, 2.9 million+
pharmacology data points, 560,000+ drugs and biologics, 340,000+
clinical trials, 95,000+ deals, 200,000+ regulatory documents and
177,000+ company profiles, among other content.
About Cortellis
Cortellis™, a Clarivate Analytics solution, gives life to
science by unlocking the hidden insights in data by curating broad
and deep sources of intelligence to enable precise, actionable
answers to specific questions across the R&D lifecycle — from
discovery and clinical development through regulatory submission
and commercialization. By supporting data-driven
decisions, Cortellis helps pharmaceutical companies,
biotech and medical device/diagnostic firms accelerate innovation.
For more information, please
visit clarivate.com/cortellis.
About Clarivate Analytics
Clarivate Analytics™ is a global leader in providing trusted
insights and analytics to accelerate the pace of innovation. We
have built some of the most trusted brands across the innovation
lifecycle, including Web of Science™, Cortellis™,
Derwent™, CompuMark™, MarkMonitor™ and Techstreet™. Today,
Clarivate Analytics is on a bold entrepreneurial mission to
help customers reduce the time from new ideas to
life-changing innovations. For more information, please
visit clarivate.com.
Forward-Looking Statements
This press release and oral statements included herein may contain
forward-looking statements regarding Clarivate Analytics.
Forward-looking statements provide Clarivate Analytics' current
expectations or forecasts of future events and may include
statements regarding results, anticipated synergies and other
future expectations. These statements involve risks and
uncertainties including factors outside of Clarivate Analytics'
control that may cause actual results to differ materially.
Clarivate Analytics undertakes no obligation to update or revise
the statements made herein, whether as a result of new information,
future events or otherwise.
Media Contact:
Tabita
Seagrave
e: media.enquiries@clarivate.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/clarivate-analytics-expands-global-life-science-alliances-program-with-three-new-technology-partners-300969319.html
SOURCE Clarivate Analytics